EN | FR
Pro Green Tea is a standardized green tea extract providing 1,500 mg of epigallocatechin gallate (EGCG) to match human clinical studies and contains a small amount of caffeine for a synergistic effect.
EGCG from green tea has been shown to promote normal cell growth and development. In addition to being a potent antioxidant, it has anti-inflammatory and anti-cancer, and anti-aging properties.
Pro Green Tea has the highest standardization for EGCG and contains 30 more capsules than AOR Active Green Tea to support long-term antioxidant supplement regimens. Just three capsules of AOR Pro Green Tea equate to 10 cups of sencha green tea.
Green tea catechins help protect plasma and lipoproteins from oxidative damage by increasing blood antioxidant capacity. Studies report health benefits in individuals drinking 10 cups a day of tea high in phytonutrient EGCg.
To equate the EGCg consumption of the best Japanese studies, take one capsule three times daily with food, or as directed by a qualified health care practitioner.
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner for use beyond 12 weeks, if you have a liver disorder, or if you have an iron deficiency. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally). Discontinue use if you develop symptoms of liver trouble, such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/ or loss of appetite and consult a health care practitioner.
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with a health care practitioner if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.
• Normal cell growth and differentiation
• Cardiovascular health
• General health
Non-medicinal Ingredients: Ascorbyl palmitate, sodium stearyl fumarate
The beneficial components of green tea, known as catechins, have antioxidant, anti-inflammatory and anti-cancer properties. Green tea has been found to reduce the risk of coronary artery disease and heart attack, and catechins have been shown to decrease blood levels of oxidized LDL. Significant benefits have also been shown in a clinical trial of Systemic Lupus Erythematosus (SLE) whereby 1,000 mg daily of green tea extract improved physical function, general health, and significantly decreased scores on the SLE disease activity index.1
Epigallocatechin gallate (EGCG) is a polyphenolic compound in green tea possessing many antioxidant, anti-mutagenic, and anti-inflammatory properties, and has been shown to decrease the viability of cervical cancer cells.2
How Much Tea?
Epidemiological evidence has shown a protective effect from consuming ten or more cups of Japanese sencha daily. As this is uncommon for Westerners, the benefits of green tea can be accessed instead with standardized extracts.
The Role of Caffeine
The synergistic effect of green tea’s many compounds, including caffeine, has been well documented. Consistent with green tea extracts used in clinical studies, small but identifiable amounts of caffeine are often included. On its own, caffeine presents as a chemotherapeutic agent: At low doses, caffeine has been shown to promote anti-tumour immune responses, and inhibit tumour angiogenesis and migration by antagonizing adenosine receptors.3
Shamekhi Z. et al. A randomized, double-blind, placebo-controlled clinical trial examining the effects of green tea extract on systemic lupus erythematosus disease activity and quality of life. Phytother Res. 2017; 31(7): 1063-71
Sharma C. et al. (-)-Epigallocatechin-3-Gallate Induces Apoptosis and Inhibits Invasion and Migration of Human Cervical Cancer Cells. Asian Pac J Cancer Prev. 2012; 13(9): 4815-4822
Tej GNVC and Nayak PK, Mechanistic considerations in chemotherapeutic activity of caffeine. Biomed Pharmacother. 2018; 105: 312-9